je.st
news
Samsung merger to drive growth in biopharmaceutical business
2015-07-20 13:25:34| Semiconductors - Topix.net
Boosted by the successful merger of Samsung C&T and Cheil Industries last week, Samsung Group is geared to step up its efforts to expand and develop its biopharmaceutical business, seen by the group as a future growth engine. The $8 billion merger has tightened the group's grip on Samsung BioLogics, the conglomerate's biopharmaceutical business unit.
Tags: business
drive
growth
samsung
Category:Electronics and Electrical
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||